Effect of Flex-a-New on Osteoarthritis of the Knee

Rabin Medical Center80 enrolled

Overview

comparative trial of placebo versus flex-a-new (a food supplement) containing glucosamine an chondroitin sulfate for the symptom modification is knee osteoarthritis

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Osteoarthritis

Interventions

flex-a-new (food supplement)DRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 85 Years

Medical Language ↔ Plain English

Inclusion Criteria: knee osteoarthritis grade 1 to 3 - Exclusion Criteria: ischemic heart disease with CHF -

Locations (1)

Rabin Medical Center

Petah Tikwa, Israel

RECRUITING

Outcomes

Primary Outcomes

KOOS

Secondary Outcomes

VAS KSS

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.